Trial Profile
Phase I trial comparing exposure after single oral and intravenous doses of delafloxacin in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jan 2016
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary) ; Delafloxacin (Primary)
- Indications Gonorrhoea; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors Melinta Therapeutics
- 12 Dec 2015 Results of this study and other two studies (n=94) published in the Clinical Therapeutics
- 08 Oct 2014 New trial record
- 11 Aug 2014 Complete results will be reported at the 54th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), according to a Melinta Therapeutics media release.